In our study, approximately one-fourth of pediatric patients with high-risk aPL profiles had a history of thrombosis, consistent with previous studies in adult APS populations, highlighting the importance of high-risk aPL profiles as a marker of thrombotic risk [8, 9]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.